Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

Share Price Information for Myhlth Chck (MHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: -0.25 (-2.33%)
Spread: 1.00 (10.00%)
Open: 10.75
High: 10.75
Low: 10.50
Prev. Close: 10.75
MHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

3 Mar 2022 13:05

RNS Number : 5589D
MyHealthChecked PLC
03 March 2022
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

MyHealthChecked plc

("MyHealthChecked" or "the Company")

 

Directorate Change

 

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces that Gareth Davies, Chief Financial and Operations Officer, will stand down and leave the Company on 7 April 2022 to pursue other opportunities.

 

Gareth joined MyHealthChecked in June 2021 and has supported the Company through a transitionary period, establishing robust financial processing and reporting systems as well as an efficient operations system. During this time, the Company has seen strong delivery through a dynamic growth phase and, with the infrastructure and new systems in place, is well placed to continue this growth through the launch of the Company's new at-home wellness tests in H1 2022.

 

The Company has initiated a search for a replacement Finance Director and a further announcement will be made in due course.

 

Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said: "I would like to thank Gareth for the critical role he has played in the past nine months at MyHealthChecked. During this time, we have achieved rapid growth and scale up, and Gareth leaves the infrastructure of MyHealthChecked in a position fitting for a public company entering a new phase of the business with COVID as a secondary business stream.

 

"Gareth has been a well-received member of the MyHealthChecked leadership team, and I wish him well in his future endeavours."

 

For further information contact:

 

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

Oberon Capital Ltd (Broker)

Tel: +44 (0)203 179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

 

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGGFFFMGZZM
Date   Source Headline
11th Jan 20247:00 amRNSTrading Update
27th Dec 202312:58 pmRNSHolding(s) in Company
25th Sep 20231:13 pmRNSGrant of Options
19th Sep 20237:00 amRNSHalf-Year Report
4th Sep 20237:00 amRNSNotice of Results
8th Aug 20237:00 amRNSTrading update
26th Jul 20237:00 amRNSDirectorate Change
26th Jun 20237:00 amRNSDirectorate Change
18th May 20237:00 amRNSAgreement with Boots for extended retail launch
11th May 202311:19 amRNSResults of AGM and Share Consolidation
11th May 20237:00 amRNSAGM Statement
9th May 20238:36 amRNSStatement re. online comment
3rd May 20237:00 amRNSHealth Inspectorate Wales registration
12th Apr 20237:00 amRNSEstablishment of an Employee Benefit Trust
3rd Apr 20237:01 amRNSProposed Share Consolidation and Notice of AGM
3rd Apr 20237:00 amRNSPreliminary Results
29th Mar 202310:00 amRNSNotice of Results
31st Jan 20237:00 amRNSTrading Update
18th Jan 20237:01 amRNSConfirmation of Capital Reduction
18th Jan 20237:00 amRNSAppointment of Dowgate as Broker
6th Dec 202212:23 pmRNSResult of General Meeting
24th Nov 202210:37 amRNSDirector/PDMR Shareholding
18th Nov 20224:40 pmRNSSecond Price Monitoring Extn
18th Nov 20224:35 pmRNSPrice Monitoring Extension
18th Nov 20227:00 amRNSProposed Capital Reduction and Notice of GM
25th Oct 202211:36 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSGrant of Options
21st Sep 20227:00 amRNSHalf-Year Report
23rd Aug 20227:00 amRNSNotice of Results
4th Aug 20227:00 amRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSAt-home wellness tests to launch on Amazon
20th Jul 20227:00 amRNSTrading update
30th Jun 202210:40 amRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement
17th Jun 20222:05 pmRNSSecond Price Monitoring Extn
17th Jun 20222:00 pmRNSPrice Monitoring Extension
14th Jun 20227:00 amRNSLaunch of at-home wellness tests
7th Jun 20224:40 pmRNSSecond Price Monitoring Extn
7th Jun 20224:35 pmRNSPrice Monitoring Extension
7th Jun 20227:00 amRNSPreliminary Results
1st Jun 20229:00 amRNSPrice Monitoring Extension
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
20th May 20222:05 pmRNSSecond Price Monitoring Extn
20th May 20222:00 pmRNSPrice Monitoring Extension
20th May 202211:06 amRNSSecond Price Monitoring Extn
20th May 202211:00 amRNSPrice Monitoring Extension
20th May 20229:05 amRNSSecond Price Monitoring Extn
20th May 20229:00 amRNSPrice Monitoring Extension
11th Apr 20227:00 amRNSDirectorate Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.